Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

ONT-093 - CAS# 216227-54-2 0154 ) exhibits an anti-tumor effect

SKU: 87970990701

4.3
SEK113.00 SEK141.00

Pay in 4 interest-free payments of $28.25 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Live Spec

ONT-093 - CAS# 216227-54-2 0154 ) exhibits an anti-tumor effectONT 093, CAS No. 216227 54 2, also known as OC 144 093, is an orally bioavailable P glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy. ONT 093 could inhibit P gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics. OC144 093 is the least non specifically toxic Pgp inhibitor described to date, with an average cytostatic IC50 of >60

Store: nyherosfund.org · Domain: nyherosfund.org

Description

) exhibits an anti-tumor effect on pancreatic cancer xenografts in mice

Aticaprant (CERC-501) alleviates the nicotine withdrawal syndrome

Solubility: DMSO: < 7 mg/mL

(2011) Cancer Research

ONT-093 - CAS# 216227-54-2 0154 ) exhibits an anti-tumor effectONT 093, CAS No. 216227 54 2, also known as OC 144 093, is an orally bioavailable P glycoprotein pump inhibitor, for the potential reversal of multidrug resistance in patients undergoing cancer chemotherapy. ONT 093 could inhibit P gp and reverse multidrug resistance at nM concentrations with no effect on paclitaxel pharmacokinetics. OC144 093 is the least non specifically toxic Pgp inhibitor described to date, with an average cytostatic IC50 of >60

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products